Results 141 to 150 of about 57,449 (202)

Risks associated with sublingual buprenorphine prescribing, dispensing and administration. [PDF]

Aust Prescr
Canning M, Suckling B, Varitimos M.
europepmc   +1 more source

Marketing Buprenorphine for Chronic Pain Management: Overcoming Societal Perceptions and Enhancing Public Health

Marc Perez-Espinosa, Nile M. Khanfar, Omar Attarabeen, Huy Pham, Georgina Silva-Suárez, Bahaudin G. Mujtaba   +5 more
openalex   +1 more source

Seven Steps for Emergency Physicians to Dismantle Access Barriers and Build Equitable Care Systems. [PDF]

West J Emerg Med
Gonzalez AM, Keating E, Moulin A.
europepmc   +1 more source

Dialing In or Dialing Out? The Relationship Between State Telemedicine Law and Access to Buprenorphine

Stacey A. Tovino
openalex   +2 more sources

Buprenorphine Substitution as a Tapering Strategy for Opioid Discontinuation in Patients with Chronic Pain: A Nonrandomized and Proof of Concept Study. [PDF]

Pain Ther
Bertin C, Kerckhove N, Ferrer F, Pereira B, Duale C, Richard D, Authier N, Delage N.   +7 more
europepmc   +1 more source

Clinical strategies for low-dose overlap initiation of buprenorphine and potential barriers to use. [PDF]

Ment Health Clin
Smith A, Weslosky K, Haynes A, Crew D.
europepmc   +1 more source

Implementing incentives in family medicine for opioid use disorder treatment: a qualitative inquiry on provider and patient preferences for a low magnitude reward program compatible with buprenorphine treatment

Samantha Ellis, Jax Witzig, Diego Basaldu, Brittany N. Rudd, Nicole Gastala, Alexandra R. Tabachnick, Sungha Kang, Tondalaya Henry, Nathan Stackhouse, Margaret C. Wardle   +9 more
openalex   +1 more source

Trends in Methadone Use for Pain and Opioid Use Disorder Among Medicaid Enrollees.

JAMA Health Forum
Hsu YS, Thakrar AP, Leonard CE, Lowenstein M, Brensinger CM, Bilker WB, Bogar KF, Hennessy S.   +7 more
europepmc   +1 more source